The Coronavirus (COVID-19) pandemic suddenly and permanently changed healthcare delivery and the economics of healthcare services and other digital health products and services in the United States and around the world. This seismic, virtually overnight transformation, has flung open doors to innovation, as a diverse cross-section of digital health and life sciences stakeholders mobilize crisis resources; adjust operations for enhanced screening, sanitization and social distancing measures; harness telehealth capabilities to deliver healthcare remotely and identify opportunities for smarter, better healthcare going forward.
We highlight the challenges and opportunities that digital health and life sciences operators and investors should consider as the industry charts a course through the post-pandemic changed healthcare landscape.
